![[höher]](/style/images/multi_up.png)
Eine Ebene höherGruppiert nach:
Dokumententyp
| Veröffentlichungsdatum
Springe zu: Zeitschriftenartikel
Anzahl der Publikationen: 14
Zeitschriftenartikel
de Gregorio, Amelie; Janni, Wolfgang; Friedl, Thomas W. P.; Nitz, Ulrike; Rack, Brigitte; Schneeweiss, Andreas; Kates, Ronald; Fehm, Tanja; Kreipe, Hans; Christgen, Matthias; Kuemmel, Sherko; Trapp, Elisabeth; Wuerstlein, Rachel; Haertkopf, Andreas; Clemens, Michael; Reimer, Toralf; Haeberle, Lothar; Fasching, Peter A.; Gluz, Oleg und Harbeck, Nadia
(2022):
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C.
In: British Journal of Cancer, Bd. 126, Nr. 12: S. 1715-1724
Vilsmaier, Theresa; Heidegger, Helene Hildegard; Schröder, Lennard; Trapp, Elisabeth; Zehni, Alaleh Zati; Rack, Brigitte; Janni, Wolfgang; Mahner, Sven; Weissenbacher, Tobias; Jeschke, Udo und Mumm, Jan-Niclas
(2021):
Interleukin 15 and Eotaxin correlate with the outcome of breast cancer patients vice versa independent of CTC status.
In: Archives of gynecology and obstetrics, Bd. 303, Nr. 1: S. 217-230
[PDF, 1MB]
Trapp, Elisabeth; Janni, Wolfgang; Schindlbeck, Christian; Jueckstock, Julia; Andergassen, Ulrich; de Gregorio, Amelie; Alunni-Fabbroni, Marianna; Tzschaschel, Marie; Polasik, Arkadius; Koch, Julian G.; Friedl, Thomas W. P.; Fasching, Peter A.; Haeberle, Lothar; Fehm, Tanja; Schneeweiss, Andreas; Beckmann, Matthias W.; Pantel, Klaus; Müller, Volkmar; Rack, Brigitte und Scholz, Christoph
(2019):
Presence of Circulating Tumor Cells in High-Risk Early Breast Cancer During Follow-Up and Prognosis.
In: Jnci-Journal of the National Cancer Institute, Bd. 111, Nr. 4, djy152: S. 380-387
Deniz, Miriam; DeGregorio, Amelie; DeGregorio, Nikolaus; Bekes, Inga; Widschwendter, Peter; Schochter, Fabienne; Ernst, Kristina; Scholz, Christoph; Bauer, Emanuel C. A.; Aivazova-Fuchs, Viktoria; Weissenbacher, Tobias; Kost, Bernd; Jueckstock, Julia; Andergassen, Ullrich; Steidl, Julia; Trapp, Elisabeth; Fasching, Peter A.; Haeberle, Lothar; Beckmann, Matthias W.; Schneeweiss, Andreas; Schrader, Iris; Janni, Wolfgang; Rack, Brigitte und Friedl, Thomas W. P.
(2019):
Differential prognostic relevance of patho-anatomical factors among different tumor-biological subsets of breast cancer: Results from the adjuvant SUCCESS A study.
In: Breast, Bd. 44: S. 81-89
Schochter, Fabienne; Rack, Brigitte; Tzschaschel, Marie; Polasik, Arkadius; Andergassen, Ulrich; Trapp, Elisabeth; Alunni-Fabbroni, Marianna; Schneeweiss, Andreas; Müller, Volkmar; Pantel, Klaus; Gade, Jörg; Lorenz, Ralf; Rezai, Mahdi; Tesch, Hans; Soeling, Ulrike; Fehm, Tanja; Mahner, Sven; Schindlbeck, Christian; Lichtenegger, Werner; Beckmann, Matthias W.; Fasching, Peter A.; Janni, Wolfgang und Friedl, Thomas W. P.
(2018):
Endocrine Treatment with 2 Years of Tamoxifen versus 2 Years of Exemestane in Postmenopausal Patients with High-Risk Early Breast Cancer and Persisting Circulating Tumor Cells - First Results of the SUCCESS C Endocrine Treatment Sub-Study.
In: Oncology Research and Treatment, Bd. 41, Nr. 3: S. 93-98
Schramm, Amelie; Schochter, Fabienne; Friedl, Thomas W. P.; Greqorio, Nikolaus de; Andergassen, Ulrich; Alunni-Fabbroni, Marianna; Trapp, Elisabeth; Jaeger, Bernadette; Heinrich, Georg; Camara, Oumar; Decker, Thomas; Ober, Angelika; Mahner, Sven; Fehm, Tanja N.; Pantel, Klaus; Fasching, Peter A.; Schneeweiss, Andreas; Janni, Wolfgang und Rack, Brigitte K.
(2017):
Prevalence of Circulating Tumor Cells After Adjuvant Chemotherapy With or Without Anthracyclines in Patients With HER2-negative, Hormone Receptor-positive Early Breast Cancer.
In: Clinical Breast Cancer, Bd. 17, Nr. 4: S. 279-285
Jueckstock, Julia; Rack, Brigitte; Friedl, Thomas W. P.; Scholz, Christoph; Steidl, Julia; Trapp, Elisabeth; Tesch, Hans; Forstbauer, Helmut; Lorenz, Ralf; Rezai, Mahdi; Häberle, Lothar; Alunni-Fabbroni, Marianna; Schneeweiss, Andreas; Beckmann, Matthias W.; Lichtenegger, Werner; Fasching, Peter A.; Pantel, Klaus und Janni, Wolfgang
(2016):
Detection of circulating tumor cells using manually performed immunocytochemistry (MICC) does not correlate with outcome in patients with early breast cancer - Results of the German SUCCESS-A- trial.
In: BMC Cancer
16:401
[PDF, 1MB]
Ignatiadis, Michail; Rack, Brigitte; Rothé, Francoise; Riethdorf, Sabine; Decraene, Charles; Bonnefoi, Hervé; Dittrich, Christian; Messina, Carlo; Beauvois, Melanie; Trapp, Elisabeth; Goulioti, Theodora; Tryfonidis, Konstantinos; Pantel, Klaus; Repollet, Madeline; Janni, Wolfgang; Piccart, Martine; Sotiriou, Christos; Litiere, Saskia und Pierga, Jean-Yves
(2016):
Liquid biopsy-based clinical research in early breast cancer: The EORTC 90091-10093 Treat CTC trial.
In: European Journal of Cancer, Bd. 63: S. 97-104
Schramm, Amelie; Friedl, Thomas W. P.; Schochter, Fabienne; Scholz, Christoph; De Gregorio, Nikolaus; Huober, Jens; Rack, Brigitte; Trapp, Elisabeth; Alunni-Fabbroni, Marianna; Müller, Volkmar; Schneeweiss, Andreas; Pantel, Klaus; Meier-Stiegen, Franziska; Hartkopf, Andreas; Taran, Florin-Andrei; Wallwiener, Diethelm; Janni, Wolfgang und Fehm, Tanja
(2016):
Therapeutic intervention based on circulating tumor cell phenotype in metastatic breast cancer: concept of the DETECT study program.
In: Archives of Gynecology and Obstetrics, Bd. 293, Nr. 2: S. 271-281
Hepp, Philip; Andergassen, Ulrich; Jäger, Bernadette; Trapp, Elisabeth; Alunni-Fabbroni, Marianna; Friedl, Thomas W. P.; Hecker, Nadeschda; Lorenz, Ralf; Fasching, Peter; Schneeweiss, Andreas; Fehm, Tanja; Janni, Wolfgang und Rack, Brigitte
(2016):
Association of CA27.29 and Circulating Tumor Cells Before and at Different Times After Adjuvant Chemotherapy in Patients with Early-stage Breast Cancer - The SUCCESS Trial.
In: Anticancer Research, Bd. 36, Nr. 9: S. 4771-4776
Rack, Brigitte; Zombirt, Ewa; Trapp, Elisabeth; Jückstock, Julia; Andergassen, Ulrich; Neugebauer, Julia; Kost, Bernd; Weissenbacher, Tobias; Jeschke, Udo; Schindlbeck, Christian; Janni, Wolfgang und Alunni-Fabbroni, Marianna
(2016):
Comparison of HER2 Expression in Primary Tumor and Disseminated Tumor Cells in the Bone Marrow of Breast Cancer Patients.
In: Oncology, Bd. 90, Nr. 4: S. 232-238
[PDF, 207kB]
Rack, Brigitte; Jückstock, Julia; Trapp, Elisabeth; Weissenbacher, Tobias; Alunni-Fabbroni, Marianna; Schramm, Amelie; Widschwendter, Peter; Lato, Krisztian; Zwingers, Thomas; Lorenz, Ralf; Tesch, Hans; Schneeweiss, Andreas; Fasching, Peter; Mahner, Sven; Beckmann, Matthias W.; Lichtenegger, Werner und Janni, Wolfgang
(2016):
CA27.29 as a tumour marker for risk evaluation and therapy monitoring in primary breast cancer patients.
In: Tumor Biology, Bd. 37, Nr. 10: S. 13769-13775
Koenig, Alexander; Vilsmaier, Theresa; Rack, Brigitte; Friese, Klaus; Janni, Wolfgang; Jeschke, Udo; Andergassen, Ulrich; Trapp, Elisabeth; Jückstock, Julia; Jaeger, Bernadette; Alunni-Fabbroni, Marianna; Friedl, Thomas W. P. und Weissenbacher, Tobias
(2016):
Determination of Interleukin-4,-5,-6,-8 and-13 in Serum of Patients with Breast Cancer Before Treatment and its Correlation to Circulating Tumor Cells.
In: Anticancer Research, Bd. 36, Nr. 6: S. 3123-3130
Widschwendter, Peter; Friedl, Thomas W. P.; Schwentner, Lukas; DeGregorio, Nikolaus; Jaeger, Bernadette; Schramm, Amelie; Bekes, Inga; Deniz, Miriam; Lato, Krisztian; Weissenbacher, Tobias; Kost, Bernd; Andergassen, Ulrich; Jueckstock, Julia; Neugebauer, Julia; Trapp, Elisabeth; Fasching, Peter A.; Beckmann, Matthias W.; Schneeweiss, Andreas; Schrader, Ines; Rack, Brigitte; Janni, Wolfgang und Scholz, Christoph
(2015):
The influence of obesity on survival in early, high-risk breast cancer: results from the randomized SUCCESS A trial.
In: Breast Cancer Research
17:129
[PDF, 1MB]